Neuroblastoma — Trials

Neuroblastoma — Trials · CancerIndex

Clinical trials

Registered studies

616 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 75
Ph III recruiting: 8
Growth YoY: −28%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (80)

clinicaltrialsPublishedShowing 51–100 of 117 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00436852	ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment	completed	Phase 2	92	Children's Oncology GroupNETWORK	2	Jul 17, 2019	clinicaltrials
NCT00793845	Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma	completed	Phase 2	40	Samsung Medical CenterOTHER	1	Sep 18, 2018	clinicaltrials